Drugs & Aging

Papers
(The H4-Index of Drugs & Aging is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Seizures and Epilepsy After Stroke: Epidemiology, Biomarkers and Management84
Depression in Patients with Parkinson’s Disease: Current Understanding of its Neurobiology and Implications for Treatment51
Problematic Opioid Use Among Older Adults: Epidemiology, Adverse Outcomes and Treatment Considerations44
Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models36
Hormonal Agents for the Treatment of Depression Associated with the Menopause34
The FORTA (Fit fOR The Aged) List 2021: Fourth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults32
Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects28
Opioids and Falls Risk in Older Adults: A Narrative Review27
Adjunctive Perampanel in Older Patients With Epilepsy: A Multicenter Study of Clinical Practice27
Diagnostic and Management Strategies for Patients with Chronic Prostatitis and Chronic Pelvic Pain Syndrome25
Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study25
Safety and Tolerability of Antimicrobial Agents in the Older Patient25
Drug–Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy23
Pulmonary Tuberculosis in Older Adults: Increased Mortality Related to Tuberculosis Within Two Months of Treatment Initiation23
A Phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Therapeutic Efficacy of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alz23
Onychomycosis in Older Adults: Prevalence, Diagnosis, and Management21
Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial21
Effects of Resveratrol Supplementation on the Cognitive Function of Patients with Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials20
Current Insights into Treating Vertigo in Older Adults20
Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011–2022 Update20
0.059031963348389